R-CHOP regimen

(Redirected from R-CHOP)
Jump to navigation Jump to search

WikiDoc Resources for R-CHOP regimen

Articles

Most recent articles on R-CHOP regimen

Most cited articles on R-CHOP regimen

Review articles on R-CHOP regimen

Articles on R-CHOP regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on R-CHOP regimen

Images of R-CHOP regimen

Photos of R-CHOP regimen

Podcasts & MP3s on R-CHOP regimen

Videos on R-CHOP regimen

Evidence Based Medicine

Cochrane Collaboration on R-CHOP regimen

Bandolier on R-CHOP regimen

TRIP on R-CHOP regimen

Clinical Trials

Ongoing Trials on R-CHOP regimen at Clinical Trials.gov

Trial results on R-CHOP regimen

Clinical Trials on R-CHOP regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on R-CHOP regimen

NICE Guidance on R-CHOP regimen

NHS PRODIGY Guidance

FDA on R-CHOP regimen

CDC on R-CHOP regimen

Books

Books on R-CHOP regimen

News

R-CHOP regimen in the news

Be alerted to news on R-CHOP regimen

News trends on R-CHOP regimen

Commentary

Blogs on R-CHOP regimen

Definitions

Definitions of R-CHOP regimen

Patient Resources / Community

Patient resources on R-CHOP regimen

Discussion groups on R-CHOP regimen

Patient Handouts on R-CHOP regimen

Directions to Hospitals Treating R-CHOP regimen

Risk calculators and risk factors for R-CHOP regimen

Healthcare Provider Resources

Symptoms of R-CHOP regimen

Causes & Risk Factors for R-CHOP regimen

Diagnostic studies for R-CHOP regimen

Treatment of R-CHOP regimen

Continuing Medical Education (CME)

CME Programs on R-CHOP regimen

International

R-CHOP regimen en Espanol

R-CHOP regimen en Francais

Business

R-CHOP regimen in the Marketplace

Patents on R-CHOP regimen

Experimental / Informatics

List of terms related to R-CHOP regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: Rituximab-Cyclophosphamide-Hydroxydaunorubicin-Oncovin-Prednisone regimen

Overview

R-CHOP regimen refers to an immunochemotherapy regimen consisting of rituximab, cyclophosphamide, hydroxydaunorubicin hydrochloride (doxorubicin hydrochloride), vincristine (Oncovin) and prednisone used to treat both indolent and aggressive forms of non-Hodgkin lymphoma.[1][2]

Regimen

RRituximab

CCyclophosphamide

HDoxorubicin (Hydroxydaunomycin)

OVincristine (Oncovin)

PPrednisone

Indications

References

  1. "NCI Thesaurus".
  2. "R-CHOP - National Cancer Institute".
  3. Coiffier, Bertrand (2002-01-24). "CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma". The New England Journal of Medicine. 346 (4): 235–242. doi:10.1056/NEJMoa011795. ISSN 1533-4406. PMID 11807147. Unknown parameter |coauthors= ignored (help)
  4. Kluin-Nelemans, H. C. (2012-08-09). "Treatment of older patients with mantle-cell lymphoma". The New England Journal of Medicine. 367 (6): 520–531. doi:10.1056/NEJMoa1200920. ISSN 1533-4406. PMID 22873532. Unknown parameter |coauthors= ignored (help)